Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

New microscopy technique could help diagnose and treat brain tumours

The high-resolution imaging method reveals new cells and structures in human brain tissue

- PMLiVE

Education, awareness, collaboration – the journey to increase biosimilar adoption in Europe

Why the future of biosimilars in Europe depends on increasing education and awareness for all

- PMLiVE

Medscape Education’s Dedication to Delivering Impact to be Highlighted at Alliance Annual Meeting 2024

Being an active part of the continuing medical education community is a top priority for the Medscape Education team. As part of their commitment to sharing their insights and learnings...

Medscape Education

Biogen Idec building

Biogen to discontinue Alzheimer’s drug Aduhelm in favour of Eisai-partnered Leqembi

The post-marketing confirmatory study of the intravenous treatment will now be terminated

- PMLiVE

DNA-based vaccine induces strong antibody response against SARS-CoV-2

The DNA scaffold carries multiple copies of a viral antigen which mimics virus structures

- PMLiVE

Almirall and Microsoft partner to accelerate digital transformation in medical dermatology

The alliance is aimed at advancing the research of solutions for dermatological diseases

- PMLiVE

NICE recommends better targeting of antibiotics for suspected sepsis

It is hoped that the new guidance will reduce the risk of antibiotic resistance by ensuring antibiotics are targeted to those at the greatest risk

- PMLiVE

It’s a new year! (Thank goodness, do I hear you cry?)

Taking the opportunity to start afresh, with a whole year to achieve our goals

- PMLiVE

We Can Shorten the Journey

During the shortest month of the year, Medscape Education is making a renewed commitment to use clinician education to help shorten the diagnostic and treatment journey for the millions of...

Medscape Education

regeneron headquarters

Regeneron to acquire 2seventy’s investigational cell therapy pipeline

An estimated 150 2seventy employees will join Regeneron’s new research and development unit

- PMLiVE

More than £30m worth of illegal medicines seized in UK during 2023

The MHRA and law enforcement partners seized over 15.5 million doses of illegal medicines

- PMLiVE

Merck shares positive results for Keytruda in phase 3 bladder cancer study

About 83,000 people in the US will be diagnosed with bladder cancer in 2024

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links